In a relapsing and remitting murine model of MS, myelin oligodendrocyte glycoprotein (MOG)-immunized mice exhibited increased M2-microglial expansion immediately preceding remission [19,92]. The gene discussed is MOG; the disease is myeloid sarcoma.